BIO 2015 Dispatches: Roche Hunts For Assets, Not Companies
This article was originally published in The Pink Sheet Daily
Executive Summary
Roche’s strong deal-making position is at least partly due to its acquisition of Genentech, but partnering head Sophie Kornowski-Bonnet explained that the firm is more interested in looking for drugs than bolt-on companies.